Active surveillance eligibility of MRI-positive patients with grade group 2 prostate cancer: a pathological study.
Ploussard G, Beauval JB, Lesourd M, Manceau C, Almeras C, Aziza R, Gautier JR, Loison G, Portalez D, Salin A, Tollon C, Soulié M, Malavaud B, Roumiguié M.
Ploussard G, et al. Among authors: almeras c.
World J Urol. 2020 Jul;38(7):1735-1740. doi: 10.1007/s00345-019-02973-7. Epub 2019 Oct 14.
World J Urol. 2020.
PMID: 31612251